tiprankstipranks
Trending News
More News >
Carisma Therapeutics (CARM)
NASDAQ:CARM

Carisma Therapeutics (CARM) Revenue

Compare
1,627 Followers

Carisma Therapeutics Revenue

Carisma Therapeutics had a revenue of 3.73M in the quarter ending Mar 31, 2025, with 2.08%. This bring the company's revenue in the last twelve months to 19.96M, Decreased 1.69%. In the fiscal year ending Dec 31, 2024, Carisma Therapeutics had annual revenue of 19.63M with 31.59% growth.
Revenue (ttm)
19.96M
Revenue Growth
32.45%
P/S Ratio
0.94
Revenue/Employee
$426,783
Employees
46
Market Cap
$18.43M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
19.63M4.71M+31.59%
Dec 31, 2023
14.92M5.08M+51.71%
Dec 31, 2022
9.83M-16.71M-62.95%
Dec 31, 2021
26.54M15.31M+136.24%
Dec 31, 2020
11.24M+∞%
Dec 31, 2019
0.00
Dec 31, 2018
0.00-425.00K-100.00%
Dec 31, 2017
425.00K-29.56M-98.58%
Dec 31, 2016
29.98M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis